Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Global Herpes Market 2014-2018

Published: Dec-2014 | Format: PDF | Technavio | Number of pages: 67 | Code: MRS - 2692

 

Generally, herpes covers two different diseases: oral herpes, also known as cold sores and genital herpes. While oral herpes affects the area around the mouth, genital herpes affects area around the genitals. The HSV-1 causes oral herpes; both HSV-1 and HSV-2 cause genital herpes. HSV is a contagious virus that spread through

 

TechNavio's analysts forecast the Global Herpes market to grow at a CAGR of 10.14 percent over the period 2013-2018.

 

Covered in this Report

 

This report covers the present scenario and the growth prospects of the Global Herpes market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and vaccines used in the treatment and prevention of herpes simplex, herpes zoster and CMV infections that are available in the market.

 

The report also presents the vendor landscape and a corresponding detailed analysis of the vendors in the Global Herpes market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market.

 

Key Regions

 

Americas
APAC
EMEA

 

Key Vendors

 

Gilead Sciences
GSK
Merck
Novartis

 

Other Prominent Vendors

 

Agenus
AiCuris
aRigen Pharmaceuticals
Astellas Pharma
CytoGenix
Epiphany Biosciences
F. Hoffmann-La Roche
Genocea Biosciences
NanoBio

 

Market Driver

 

Significant Unmet Needs
For a full, detailed list, view our report

 

Market Challenge

 

Increasing Generic Competition
For a full, detailed list, view our report

 

Market Trend

 

Promising New Launches
For a full, detailed list, view our report

 

Key Questions Answered in this Report

 

What will the market size be in 2018 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors

Table of Contents


1. Executive Summary
 

2. List of Abbreviations
 

3. Scope of the Report
3.1 Market Overview
3.2 Product Offerings
3.2.1 Product Profiles

 

4. Market Research Methodology
4.1 Market Research Process
4.2 Research Methodology

 

5. Introduction
 

6. Market Landscape
6.1 Market Overview
6.2 Market Size and Forecast

 

7. Competitive Assessment of Marketed Products
7.1 Five Forces Analysis

 

8. Rate of Incidence and Prevalence
8.1.1 US
8.1.2 UK

 

9. Diagnosis of Herpes
 

10. Market Segmentation by Product Type
 

11. Market Segmentation by Type of Virus
 

12. Market Assessment of Top Drugs
12.1 Zovirax
12.1.1 Sales
12.2 Valtrex
12.2.1 Sales

 

13. Geographical Segmentation
 

14. Buying Criteria
 

15. Market Growth Drivers
 

16. Drivers and their Impact
 

17. Market Challenges
 

18. Impact of Drivers and Challenges
 

19. Market Trends
 

20. Trends and their Impact
 

21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2013
21.3 Other Prominent Vendors

 

22. Key Vendor Analysis
22.1 Gilead Sciences
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Geographical Segmentation by Revenue 2013
22.1.4 Recent Developments
22.1.5 SWOT Analysis
22.2 GlaxoSmithKline
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue 2012 and 2013
22.2.5 Sales by Geography
22.2.6 Pipeline Products
22.2.7 Business Strategy
22.2.8 Key Information
22.2.9 SWOT Analysis
22.3 Merck & Co. Inc.
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation by Revenue 2013
22.3.4 Business Segmentation by Revenue 2012 and 2013
22.3.5 Sales by Geography
22.3.6 Business Strategy
22.3.7 Key Developments
22.3.8 SWOT Analysis
22.4 Novartis
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis

 

23. Other Reports in this Series
 

List of Exhibits:
 

Exhibit 1: Market Research Methodology
Exhibit 2: Global Herpes Market 2013-2018 (US$ billion)
Exhibit 3: Diagnosis of Herpes
Exhibit 4: Global Herpes Market Segmentation by Type
Exhibit 5: GSK's Zovirax Revenue 2010-2013 (US$ million)
Exhibit 6: GSK's Valtrex Revenue 2010-2013 (US$ million)
Exhibit 7: Global Herpes Market by Geographical Segmentation 2013
Exhibit 8: Gilead Sciences: Geographical Segmentation by Revenue 2013
Exhibit 9: GlaxoSmithKline: Business Segmentation 2013
Exhibit 10: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 11: GlaxoSmithKline: Sales by Geography 2013
Exhibit 12: GlaxoSmithKline: Pipeline Products 2013
Exhibit 13: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 14: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 15: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 16: Novartis: Business Segmentation by Revenue 2013
Exhibit 17: Novartis: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 18: Novartis: Sales by Geography 2013

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing